Results for tag: "Cancer Biologics"

The Cancer Biologics market is a subset of the larger Biotechnology industry. It focuses on the development and commercialization of biologic drugs for the treatment of cancer. These drugs are typically derived from living organisms, such as proteins, antibodies, and other molecules, and are used to target and treat cancer cells. They are often used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Cancer biologics are typically developed through a combination of laboratory research, clinical trials, and regulatory approval. Companies in this market are typically involved in the research, development, manufacturing, and marketing of these drugs. Notable companies in the Cancer Biologics market include Amgen, Bristol-Myers Squibb, Merck, Novartis, Pfizer, and Roche. Show Less Read more